POMS
Private Company
Total funding raised: $17.5M
Overview
POMS Corporation is a mature, established software company operating in the digital health and AI/machine learning sectors, with a core focus on manufacturing execution systems (MES) for life sciences. Its primary product, POMSnet Aquila MES, is a purpose-built, validated software platform that digitizes and manages the manufacturing process, integrating enterprise and plant-floor systems to improve efficiency, compliance, and data integrity. With a claimed history dating back to 1988 and a significant track record of millions of completed work orders, POMS serves large pharmaceutical and biotech companies, generating revenue through software licensing, SaaS subscriptions, and support services. The company positions itself as an industry leader with deep domain expertise, offering both on-premise and cloud deployment models.
Technology Platform
POMSnet Aquila MES: A fully web-based, cloud-ready Manufacturing Execution System (MES) purpose-built for life sciences. It features an intuitive operator interface, 'review by exception' automation, and integrates ERP and plant-floor systems to create FDA-compliant electronic batch records.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
POMS competes in the life sciences MES segment against large industrial automation firms (e.g., Siemens, Rockwell Automation), enterprise software giants (e.g., SAP), and other niche MES providers. Its competitive edge is its deep, pharma-specific expertise, a proven track record over decades, and a platform designed specifically for operator usability and regulatory compliance.